Agile Therapeutics Revenue and Competitors

Location

$204.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Agile Therapeutics's estimated annual revenue is currently $15M per year.(i)
  • Agile Therapeutics's estimated revenue per employee is $384,615
  • Agile Therapeutics's total funding is $204.5M.

Employee Data

  • Agile Therapeutics has 39 Employees.(i)
  • Agile Therapeutics grew their employee count by -22% last year.

Agile Therapeutics's People

NameTitleEmail/Phone
1
Sr. VP, Chief Administrative Officer and Corporate SecretaryReveal Email/Phone
2
VP, Chief Accounting OfficerReveal Email/Phone
3
VP, Policy, Advocacy and AccessReveal Email/Phone
4
Head Investor Relations & Corporate CommunicationsReveal Email/Phone
5
Head Financial Planning & Operations ManagementReveal Email/Phone
6
Director Supply ChainReveal Email/Phone
7
Senior Director MarketingReveal Email/Phone
8
VP, Legal and Chief Compliance OfficerReveal Email/Phone
9
Senior Director Supply ChainReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Agile Therapeutics?

Agile Therapeutics (agiletherapeutics.com) is a development-stage company founded in 1997. The Company is focused on developing novel transdermal products to deliver therapeutic and preventive pharmaceuticals more effectively and conveniently to help women manage their healthcare needs. The Company seeks corporate partners to complete pivotal clinical evaluations and to market the products it discovers and develops.

keywords:N/A

$204.5M

Total Funding

39

Number of Employees

$15M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Agile Therapeutics News

2022-04-19 - Do Traders Think Agile Therapeutics Inc (AGRX) Can Keep Climbing Monday?

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to...

2022-03-30 - Agile Therapeutics (AGRX) Q4 2021 Earnings Call Transcript

Good afternoon, and welcome to the Agile Therapeutics fourth quarter and full year 2021 financial results conference call.

2022-03-30 - Agile Therapeutics® Announces First Twirla® Commercial ...

Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Twirla and...

2021-11-02 - AGILE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K

AGILE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021 Company Advances Programs Focused on Increasing Deman ...

2021-10-08 - Agile Therapeutics : Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants to purchase 13,333,324 shares of its common stock at a c ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M398%N/A
#2
$3.2M390%N/A
#3
N/A39-39%N/A
#4
$3.5M408%N/A
#5
$4.6M408%N/A